Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Triglyceride Effects on Blood Flow in the Human Brain [NA]
Clinical trial studying triglyceride effects on blood flow in the human brain for Alzheimer disease has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Prazosin for Agitation in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for prazosin in agitation associated with Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease [NA]
A terminated clinical trial investigated low-dose whole brain irradiation for Alzheimer's disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for PMZ-1620 (Sovateltide) in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Utilizing Senior Companions to Enhance Dementia Care [NA]
A University of Minnesota study evaluated using senior companions to enhance dementia care, and its results were posted after completion in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders [NA]
Clinical trial update on using smell, voice, and nasal swabs as markers for neuro-degenerative disorders; status completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease [Phase 3]
Phase 3 trial of sodium oligomannate (GV-971) in mild to moderate Alzheimer's disease is suspended.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease [Phase 2]
A Phase 2 trial of BIIB092 in early Alzheimer's disease was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease [Phase 2]
Phase 2 multiple IV dose study of PF-04360365 in patients with mild to moderate Alzheimer's disease has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for allogeneic human mesenchymal stem cells in Alzheimer dementia is ongoing with an unknown status.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD [Phase 2]
Phase 2 trial evaluating intermittent theta burst stimulation for mild cognitive impairment and early Alzheimer’s disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: A Study of Semorinemab in Patients With Moderate Alzheimer's Disease [Phase 2]
Phase 2 study evaluating semorinemab in patients with moderate Alzheimer's disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of AstroStem for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. [Phase 2, Phase 3]
A multicenter Phase 2/3 study evaluating potential disease-modifying treatments for individuals at risk for or with dominantly inherited ear…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) [Phase 2]
An extension study of ABBV-8E12 in early Alzheimer’s disease (Phase 2) was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Efficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial investigating a traditional Chinese medicine 'Smart Soup' for cognition and behavior regulation in Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial updating on efficacy, safety, and tolerability of AVP-786 for agitation in dementia of the Alzheimer's type (Alzheimer's disea…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) [Phase 2]
Phase 2 clinical trial update on tau brain imaging in typical and atypical Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment [NA]
Completed clinical trial studying adaptive neuroplasticity in individuals with mild cognitive impairment and Alzheimer's disease; results po…
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for LY3303560 in early symptomatic Alzheimer's disease; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating ABBV-8E12 for early Alzheimer's disease has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Tdap and Biomarkers of Alzheimer's Disease [Phase 1, Phase 2]
Phase 1 and Phase 2 trial update for a Tdap-based approach investigating biomarkers in late-onset Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression [EARLY_Phase 1]
Phase 1 study update for INCREASE exploring delaying onset of Alzheimer's symptomatic expression; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients [Phase 2]
A Phase 2 clinical trial evaluated metabolic cofactor supplementation in patients with Alzheimer's disease and Parkinson's disease; study st…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Improvisational Movement for People With Memory Loss and Their Caregivers [NA]
A completed clinical trial evaluating improvisational movement for people with memory loss and their caregivers has posted results.